Intrinsic Value of S&P & Nasdaq Contact Us

Better Therapeutics, Inc. BTTX OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
28/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — BTTX

Better Therapeutics, Inc. (BTTX) has a market capitalization of $5.45K and trades at $0.00. The 52-week range is 0.0001-0.001.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-1.69.

The stock has a beta of 1.69, operates in the Healthcare sector.

Trading Data
Current Price$0.00
52-Week Range0.0001-0.001
Volume500
Avg Volume (30D)3.15K
Market Cap$5.45K
Beta (1Y)1.69
Company
IPO Date2021-03-17
Employees54
CEODavid Perry
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS08773T1043
CUSIP08773T104
Income (Latest Year)
Gross Profit$-2.73M
EBITDA$-38.26M
Operating Income$-38.26M
Net Income$-39.76M
EPS$-1.69
EPS Diluted$-1.69
Shares Outstanding$23.56M
Balance Sheet (Latest Year)
Total Assets$22.94M
Current Assets$18.45M
Cash & ST Investments$15.74M
Total Liabilities$23.84M
Total Debt$14.88M
Net Debt$-860K
Total Equity$-899K
Debt / Equity-16.55
Valuation Ratios
P/E Ratio-0
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message